Speak about going out on a excessive. Rakesh Kapoor steps down as Reckitt Benckiser boss on September 1. So what higher parting present than this: a $1.four billion bill for the group’s drug dependancy issues?

It’s the worth of his settlement with the US Division of Justice and the Federal Change Price for Reckitt’s previous existence as a peddler of Suboxone Film: a treatment designed to wean addicts off extra sturdy opioids equal to heroin. And, sure, it’s terribly good of Mr Kapoor to pay up and save his successor, Laxman Narasimhan, the problem of dealing with the DoJ. It’s a no-fault settlement, too, with “no admission of any violation of legislation or any wrongdoing” by Reckitt or its employees. Nonetheless there’s quiet one thing impartial a minute…